Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study
Authors
Erika Hamilton (ORCID: https://orcid.org/0000-0002-1911-0336)
Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study
Erika Hamilton, Alexandre Seiller, Yanqiu Feng, Sherko Küemmel et al.
Citations
1 citations
Journal
ESMO Open
Topics
HER2/EGFR in Cancer Research
Field-Weighted Citation Impact (FWCI)
1.05
article
Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study
Erika Hamilton, Alexandre Seiller, Yanqiu Feng, Sherko Küemmel, Luis de la Cruz‐Merino, Roberto Hegg, Laise Rodrigues de Andrade, Begoña Bermejo, Ruffo Freitas‐Júnior, Max Dieterich, Kyung Hae Jung, Aneta Swat, Daniele Xavier Assad, Hilary Martin, Andreas Schneeweiß, Ran Meng, Anh Nguyen Duc, C.-S. Huang
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
ESMO OpenVol. 10(12)
Institutions
Ulsan College (KR), Roche (Switzerland) (CH), Asan Medical Center (KR), University of Ulsan (KR), Sarah Cannon (US), D’Or Institute for Research and Education (BR), National Taiwan University Hospital (TW), Hospital da Mulher São Paulo (BR), Hospital Sírio-Libanês (BR), Universidade Federal de Goiás (BR)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study — Erika Hamilton, Alexandre Seiller, et al. · ESMO Open (2025) | TGRS Research Map | TGRS